Kalled; Susan L.
Patent Applications and Registrations
Patent applications and USPTO patent grants for Kalled; Susan L..The latest application filed is for "anti-bcma antibodies".
- Kalled; Susan L. - Concord MA
- Kalled; Susan L. - Jamaica Plain MA
| Patent | Date |
|---|---|
| Anti-bcma Antibodies App 20220213208 - Kalled; Susan L. ; et al. | 2022-07-07 |
| Fusion Protein Constructs For Complement Associated Disease App 20210309728 - Curtis; Michael Steven ; et al. | 2021-10-07 |
| Anti-BCMA antibodies Grant 11,111,307 - Kalled , et al. September 7, 2 | 2021-09-07 |
| Fusion protein constructs comprising anti-C3d antibody and CR1 polypeptide Grant 11,053,305 - Curtis , et al. July 6, 2 | 2021-07-06 |
| Fusion protein constructs comprising anti-C3d antibody and factor H Grant 11,053,306 - Curtis , et al. July 6, 2 | 2021-07-06 |
| FUSION PROTEIN CONSTRUCTSCOMPRISING ANTI-C3d ANTIBODY AND FACTOR H App 20210009669 - Curtis; Michael Steven ; et al. | 2021-01-14 |
| Fusion Protein Constructs For Complement Associated Disease App 20200181249 - CURTIS; MICHAEL STEVEN ; et al. | 2020-06-11 |
| Anti-bcma Antibodies App 20190161552 - Kalled; Susan L. ; et al. | 2019-05-30 |
| Anti-bcma Antibodies App 20170029518 - Kalled; Susan L. ; et al. | 2017-02-02 |
| Anti-BCMA antibodies Grant 9,034,324 - Kalled , et al. May 19, 2 | 2015-05-19 |
| Anti-bcma Antibodies App 20150125460 - Kalled; Susan L. ; et al. | 2015-05-07 |
| Methods For Use With Baff Antagonists App 20140213470 - Hsu; Yen-Ming ; et al. | 2014-07-31 |
| Methods for use with BAFF antagonists Grant 8,617,545 - Hsu , et al. December 31, 2 | 2013-12-31 |
| Methods of evaluating BAFF Grant 8,415,111 - Hsu , et al. April 9, 2 | 2013-04-09 |
| Methods Of Evaluating Baff App 20120231481 - Hsu; Yen-Ming ; et al. | 2012-09-13 |
| Methods of evaluating BAFF Grant 8,202,698 - Hsu , et al. June 19, 2 | 2012-06-19 |
| Anti-bcma Antibodies App 20120082661 - Kalled; Susan L. ; et al. | 2012-04-05 |
| Use Of Bcma As An Immunoregulatory Agent App 20110177093 - Kalled; Susan L. ; et al. | 2011-07-21 |
| Methods for Use with Baff Antagonists App 20100330066 - Hsu; Yen-Ming ; et al. | 2010-12-30 |
| Use of Bcma as an Immunoregulatory Agent App 20080267965 - Kalled; Susan L. ; et al. | 2008-10-30 |
| Methods of Evaluating Baff App 20080268480 - Hsu; Yen-Ming ; et al. | 2008-10-30 |
| Treament of lupus nephritis with anti-CD40L compounds App 20070190053 - Kalled; Susan L. ; et al. | 2007-08-16 |
| Method of therapeutic administration of anti-CD40L compounds App 20050158314 - Kalled, Susan L. ; et al. | 2005-07-21 |
| Treatment of immune complex disease with anti-CD40L antibodies App 20030031668 - Kalled, Susan L. ; et al. | 2003-02-13 |
| Method of therapeutic administration of anti-CD40L compounds App 20020071840 - Kalled, Susan L. ; et al. | 2002-06-13 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 